倍他乐克与雅施达联用治疗慢性心力衰竭临床观察

被引：13

作者：

申向华

机构：

[1] 湖南省邵东县人民医院心内科

来源：

中国医药导报 | 2007年 / 03期

关键词：

慢性心力衰竭; 倍他乐克; 雅施达;

D O I：

暂无

中图分类号：

R541.6 [血液循环衰竭];

学科分类号：

1002 ; 100201 ;

摘要：

目的:观察倍他乐克与雅施达联用治疗慢性心力衰竭的临床疗效。方法:185例患者在应用强心、利尿、扩血管药物治疗的同时给予倍他乐克6.25mg,2次/d,2周剂量加倍,最大50mg,2次/d。雅施达2mg,1次/d,3￣7d剂量加倍,最大4mg,1次/d。观察治疗前、后30周心率、血压、NYHA心功能分级、LVESV、LVEDV、LVEF。结果:治疗后心率下降,血压降低,心功能改善,LVESV、LVEDV下降,LVEF上升,与治疗前比较有显著性差异。结论:倍他乐克与雅施达联用治疗慢性心衰,可改善症状、提高生命质量、降低病死率与住院率、改善心脏重构。

引用

页码：76 / 77

页数：2

共 9 条

[1]

Effect of carvedilol on survival in severe chronic heart failure. Packer M,Coats AJS,Fowleer MB,et al. The New England Journal of Medicine . 2001

[2]

Effect of metoprolol CR/XL in chronic heart failure:Metoprolol CR/XL randomised intervention trial in congestive heart failure(MERIT-HF). MERIT-HF Study Group. The Lancet . 1999

[3]

Chronic treatment of dilated cardiomyopathy by beta-block-ing agents:clinical and hemodynacic follow-up. Cucchini F. Eng Aabstr . 1998

[4]

The effect of carvedilol on mor-bidity and mortality in patietns with chronic heart failure. Packer M,Bristow MR,Cohn JN,et al. The New England Journal of Medicine . 1996

[5]

Eplerenone,a selective aldosterone blocker,in patients with left ventricular dysfunction after myocardial infarction. Pitt B,Remme W,Zannad F,et al. The New England Journal of Medicine . 2003

[6]

Therapeutic options in the management of chronic heart fail-ure. Packer M. Circulation . 1989

[7]

Long-term,dose-dependent effects of spironolactone on left ventricular function and exercise tolerance in patients with chronic heart failure. Cicoira M,Zanolla L,Rossi A,et al. Journal of the American College of Cardiology . 2002

[8]

Effect of eanalapril on mortality in se-vere congestive heart failure:results of the cooperative North Scandi-navian Enalapril Survival Study. The consensus trial study group. The New England Journal of Medicine . 1987

[9]

The cardiac insufficiencybisoprolol studyⅡ(CIBIS-Ⅱ)a randomised trail. CIBISⅡInvestigators and Committees. The Lancet . 1999

← 1 →